Latest Lilly Stories
INDIANAPOLIS and RIDGEFIELD, Conn., Aug. 18, 2014 /PRNewswire/ -- The U.S.
Third product from the BI-Lilly Diabetes alliance to be approved by FDA RIDGEFIELD, Conn., and INDIANAPOLIS, Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
INDIANAPOLIS, July 24, 2014 /PRNewswire/ -- -- Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S.
INDIANAPOLIS, July 10, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly for Better Health(TM) program, with several innovative enhancements to
BEIJING, July 7, 2014 /PRNewswire/ -- Yabao Pharmaceutical Co, Inc.
First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and INGELHEIM, Germany, June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human
First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and RIDGEFIELD, Conn., June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human
Anthem Blue Cross and Blue Shield and Indiana Family & Social Services Administration (FSSA)offer students insights on access to healthcare INDIANAPOLIS, June 23, 2014 /PRNewswire/
AWARD-2: Once-Weekly Dulaglutide 0.75 mg Non-Inferior, 1.5 mg Superior in HbA1c Reduction from Baseline with Sustained Weight Loss and Lower Risk for Hypoglycemia SAN FRANCISCO, June 16, 2014